Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Buy" from Analysts

Retrieved on: 2021-06-19 09:22:30

Tags for this article:

Click the tags to see associated articles and topics

Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Buy" from Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 9,507,428 shares of the biopharmaceutical company's stock valued at $409,389,000 after purchasing an additional 277,940 ...

Article found on: www.marketbeat.com